Login / Signup

A prospective compound screening contest identified broader inhibitors for Sirtuin 1.

Shuntaro ChibaMasahito OhueAnastasiia GryniukovaPetro BoryskoSergey ZozulyaNobuaki YasuoRyunosuke YoshinoKazuyoshi IkedaWoong-Hee ShinDaisuke KiharaMitsuo IwadateHideaki UmeyamaTakaaki IchikawaReiji TeramotoKun-Yi HsinVipul GuptaHiroaki KitanoMika SakamotoAkiko HiguchiNobuaki MiuraKei YuraMasahiro MochizukiChandrasekaran RamakrishnanA Mary ThangakaniD VelmuruganM Michael GromihaItsuo NakaneNanako UchidaHayase HakariyaModong TanHironori K NakamuraShogo D SuzukiTomoki ItoMasahiro KawataniKentaroh KudohSakurako TakashinaKazuki Z YamamotoYoshitaka MoriwakiKeita OdaDaisuke KobayashiTatsuya OkunoShintaro MinamiGeorge ChikenjiPhilip PrathipatiChioko NagaoAttayeb MohsenMari ItoKenji MizuguchiTeruki HonmaTakashi IshidaTakatsugu HirokawaYutaka AkiyamaMasakazu Sekijima
Published in: Scientific reports (2019)
Potential inhibitors of a target biomolecule, NAD-dependent deacetylase Sirtuin 1, were identified by a contest-based approach, in which participants were asked to propose a prioritized list of 400 compounds from a designated compound library containing 2.5 million compounds using in silico methods and scoring. Our aim was to identify target enzyme inhibitors and to benchmark computer-aided drug discovery methods under the same experimental conditions. Collecting compound lists derived from various methods is advantageous for aggregating compounds with structurally diversified properties compared with the use of a single method. The inhibitory action on Sirtuin 1 of approximately half of the proposed compounds was experimentally accessed. Ultimately, seven structurally diverse compounds were identified.
Keyphrases
  • drug discovery
  • risk assessment
  • climate change